- JP-listed companies
- Nichi-Iko Pharmaceutical Co., Ltd.
- Income statement
Nichi-Iko Pharmaceutical Co., Ltd.【JP:E00963】Income statement
Market cap
P/E ratio
| 2011/11 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | |
| Revenue | 77,740 | 93,926 | 103,622 | 127,021 | 143,513 | 163,372 | 187,863 | 166,592 | 190,076 | 188,218 | 179,060 |
| Cost of revenue | - | - | - | 79,935 | 89,999 | 106,637 | 123,914 | 133,434 | 152,756 | 166,973 | 175,094 |
| Gross profit | - | - | - | 47,086 | 53,514 | 56,735 | 40,803 | 33,157 | 37,319 | 21,245 | 3,965 |
| Gross margin (%) | - | - | - | - | - | - | - | - | |||
| Operating expenses | - | - | - | 37,484 | 40,624 | 48,186 | 23,136 | 22,504 | 25,614 | 27,029 | 27,879 |
| Operating income | - | - | - | 9,619 | 12,910 | 8,554 | 10,301 | 8,223 | 2,873 | 107 | -110,051 |
| Income before tax | 7,309 | 8,470 | 7,085 | 9,615 | 12,289 | 8,411 | 9,067 | 8,903 | 7,396 | 1,068 | -107,842 |
| Provision for income taxes | - | - | - | 2,895 | 4,328 | 2,142 | 997 | 2,039 | 2,479 | 5,342 | -2,190 |
| Net income | - | - | - | 6,592 | 11,031 | 4,788 | 8,070 | 6,864 | 5,133 | -4,179 | -104,984 |
| Earnings per share | 101.54 | 128.14 | 104.75 | 110.26 | 184.45 | 84.09 | 143.19 | 115.46 | 80.42 | -65.28 | -1,554.37 |
| Diluted EPS | 101.53 | 128.08 | 104.67 | 110.14 | 184.02 | 83.95 | 68.36 | 114.04 | 80.14 | -65.28 | -1,554.37 |
| Dividend per share | 32 | 32 | 28.3 | 26.6 | 30 | 30 | 30 | 30 | 30 | 25 | - |